External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Bex, Axel
van Werkhoven, Erik D.
Noe, Allard
Karam, Jose A.
Matin, Surena F.
Margulis, Vitaly
Stewart, Grant
Staehler, Michael D.
Wood, Christopher G.
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Munich, Dept Urol, Univ Hosp Munich Grosshadern, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
    Marconi, Lorenzo
    de Bruijn, Roderick
    van Werkhoven, Erik
    Beisland, Christian
    Fife, Kate
    Heidenreich, Axel
    Kapoor, Anil
    Karam, Jose
    Kauffmann, Caroline
    Klatte, Tobias
    Ljungberg, Boerje
    Matin, Surena
    Sjoberg, Daniel
    Staehler, Michael
    Stewart, Grant D.
    Tanguay, Simon
    Uzzo, Robert
    Welsh, Sarah
    Wood, Lori
    Wood, Chris
    Bex, Axel
    WORLD JOURNAL OF UROLOGY, 2018, 36 (12) : 1973 - 1980
  • [2] External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
    Lorenzo Marconi
    Roderick de Bruijn
    Erik van Werkhoven
    Christian Beisland
    Kate Fife
    Axel Heidenreich
    Anil Kapoor
    Jose Karam
    Caroline Kauffmann
    Tobias Klatte
    Boerje Ljungberg
    Surena Matin
    Daniel Sjoberg
    Michael Staehler
    Grant D. Stewart
    Simon Tanguay
    Robert Uzzo
    Sarah Welsh
    Lori Wood
    Chris Wood
    Axel Bex
    World Journal of Urology, 2018, 36 : 1973 - 1980
  • [3] Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
    Ghatalia, Pooja
    Handorf, Elizabeth A.
    Deng, Mengying
    Zibelman, Matthew R.
    Abbosh, Philip
    Anari, Fern
    Greenberg, Richard E.
    Viterbo, Rosalia
    Chen, David
    Smaldone, Marc C.
    Kutikov, Alexander
    Geynisman, Daniel M.
    Uzzo, Robert Guy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    Finelli, A.
    Horgan, A. M.
    Evans, A.
    Kim, T. K.
    Durrant, K.
    Yap, S.
    Cassol, C. A.
    Dubinski, W.
    Fleshner, N.
    Jewett, M. A. S.
    Joshua, A. M.
    Sridhar, S. S.
    Zlotta, A.
    Knox, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] PROGNOSTIC NOMOGRAMS FOR PREDICTION OF SURVIVAL BEFORE OR AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA
    Margulis, Vitaly
    Kattan, Michael W.
    Matin, Surena F.
    Tamboli, Pheroze
    Jonasch, Eric
    Tannir, Nizar M.
    Swanson, David A.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2009, 181 (04) : 499 - 500
  • [6] SARCOPENIA AS A PREDICTOR OF SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Caracciolo, Jamie
    Fishman, Mayer
    Poch, Michael
    Pow-Sang, Julio
    Sexton, Wade
    Spiess, Philippe
    JOURNAL OF UROLOGY, 2015, 193 (04) : E733 - E733
  • [7] Development of Accurate Models for Individualized Prediction of Survival After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Margulis, Vitaly
    Shariat, Shahrokh F.
    Rapoport, Yury
    Rink, Michael
    Sjoberg, Daniel D.
    Tannir, Nizar M.
    Abel, E. Jason
    Culp, Stephen H.
    Tamboli, Pheroze
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2013, 63 (05) : 947 - 952
  • [8] Impact of cytoreductive nephrectomy (CN) on survival in metastatic renal cell cancer (mRCC) treated with immune checkpoint inhibitors (ICI).
    Perimbeti, Stuthi
    Jiang, Changchuan
    Deng, Lei
    Roy, Arya
    Gopalakrishnan, Keerthy
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] A PROGNOSTIC MODEL FOR SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA
    Kaffenberger, Samuel D.
    Morgan, Todd M.
    Tang, Dominic H.
    Ark, Jacob T.
    Barocas, Daniel A.
    Chang, Sam S.
    Cookson, Michael S.
    Herrell, S. Duke
    Smith, Joseph A.
    Clark, Peter E.
    JOURNAL OF UROLOGY, 2012, 187 (04) : E727 - E728
  • [10] Outcome of patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy (TT) without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345